Insulin and insulin secretagogues (e.g. sulfonylurea) are recommended to be limited as rescue therapy for grade 3 hyperglycemia or when hyperglycemia is not controlled on multiple oral hypoglycemic agents (2). This evidence concerns the gene INS and Hyperglycemia.